trial · primary record
REGN5678
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 345 |
| Primary completion | 2027-11-15 |
| Primary endpoint | Incidence and severity of Treatment-Emergent Adverse Events (TEAEs) |
| Registry ID | NCT03972657 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:19.012Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03972657
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.